 treatment murin transit cell carcinoma intralesion interleukin interferon gamma antitumor effect recombin combin recombin interferon gamma murin transit cell carcinoma initi prophylact model treatment day site tumor inocul maxim signific reduct tumor volum group unit recombin interleukin coloni unit bacillu calmett guerin vs salin control experi reduct tumor incid increas surviv group unit recombin interleukin unit recombin interleukin unit recombin interferon gamma coloni unit bacillu calmett guerin rel control dose-respons effect recombin interleukin alon model transit cell carcinoma intralesion inject treatment tumor palpabl reduct tumor volum group unit recombin interleukin vs salin control signific advantag surviv